Latest filing published 09 Jan 2024 for 제넨바이오.
엠씨제2호그로우쓰사모투자: trading record in brief
엠씨제2호그로우쓰사모투자 appears in our data through filings on 제넨바이오 shares, published by DART (FSS). In total, 2 filings cover trades dated 11 December 2023.
The open-market record is one-sided, with 2 purchases worth €6.0M and not one sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2024 to date brings 2 purchases and no sales.
The newest entry dates from 9 January 2024: an open-market purchase, in 제넨바이오. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 엠씨제2호그로우쓰사모투자
Open company profiles for insider transactions, fundamentals and analyst consensus when available.